Related references
Note: Only part of the references are listed.Brachyury expression in extra-axial skeletal and soft tissue chordomas: A marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue
Roberto Tirabosco et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Identification of Nucleus Pulposus Precursor Cells and Notochordal Remnants in the Mouse: Implications for Disk Degeneration and Chordoma Formation
Kyung-Suk Choi et al.
DEVELOPMENTAL DYNAMICS (2008)
Novel therapeutic targets in bladder cancer: mutation and expression of FGF receptors
Margaret A. Knowles
FUTURE ONCOLOGY (2008)
A missense T(Brachyury) mutation contributes to vertebral malformations
Nader Ghebranious et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Drug-sensitive FGFR2 mutations in endometrial carcinoma
Amit Dutt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Frequent deletion of the CDKN2A locus in chordoma:: analysis of chromosomal imbalances using array comparative genomic hybridisation
K. H. Hallor et al.
BRITISH JOURNAL OF CANCER (2008)
Expression of hepatocyte growth factor and c-MET in skull base chordoma
Takahiko Naka et al.
CANCER (2008)
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes
P. M. Pollock et al.
ONCOGENE (2007)
Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer
K. Sahadevan et al.
JOURNAL OF PATHOLOGY (2007)
FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancer
D. C. Tomlinson et al.
JOURNAL OF PATHOLOGY (2007)
Overexpressions of nerve growth factor and its tropomyosin-related kinase a receptor on chordoma cells
Jong-Beom Park et al.
SPINE (2007)
Direct activation by Ets and Zic is required for initial expression of the Brachyury gene in the ascidian notochord
Jun Matsumoto et al.
DEVELOPMENTAL BIOLOGY (2007)
Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
Rohit Mehra et al.
MODERN PATHOLOGY (2007)
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh et al.
BREAST CANCER RESEARCH (2007)
Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas
Elena Tamborini et al.
CLINICAL CANCER RESEARCH (2006)
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho et al.
CLINICAL CANCER RESEARCH (2006)
Metastatic disease from spinal chordoma: a 10-year experience
Chrstopher M. McPherson et al.
JOURNAL OF NEUROSURGERY-SPINE (2006)
Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor
Lily Park et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas
S. Vujovic et al.
JOURNAL OF PATHOLOGY (2006)
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
Suzanne Trudel et al.
BLOOD (2006)
Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies
PM Weinberger et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2005)
Constitutively activated FGFR3 mutants signal through PLCγ-dependent and -independent pathways for hematopoietic transformation
J Chen et al.
BLOOD (2005)
A molecular map of mesenchymal tumors
SR Henderson et al.
GENOME BIOLOGY (2005)
Ets proteins in biological control and cancer
T Hsu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
TBX3 and its isoform TBX3+2a are functionally distinctive in inhibition of senescence and are overexpressed in a subset of breast cancer cell lines
WW Fan et al.
CANCER RESEARCH (2004)
The role of fibroblast growth factors and their receptors in prostate cancer
B Kwabi-Addo et al.
ENDOCRINE-RELATED CANCER (2004)
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment
CE Foulds et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
T-box genes in early embryogenesis
C Showell et al.
DEVELOPMENTAL DYNAMICS (2004)
Benign notochordal cell tumors - A comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs
T Yamaguchi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
The human T locus and spina bifida risk
LE Jensen et al.
HUMAN GENETICS (2004)
Essential role of the transcription factor ETS-2 in Xenopus early development
K Kawachi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CHI
S Scheil et al.
GENES CHROMOSOMES & CANCER (2001)
Critical role for the docking-protein FRS2α in FGF receptor-mediated signal transduction pathways
YR Hadari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Chordoma: incidence and survival patterns in the United States, 1973-1995
ML McMaster et al.
CANCER CAUSES & CONTROL (2001)
Fibroblast growth factor receptor-2 mutation analysis in human prostate cancer
P Mehta et al.
BJU INTERNATIONAL (2000)
Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation
Y Chen et al.
ONCOGENE (2000)
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
KC Hart et al.
ONCOGENE (2000)
Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer
EY Shin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Share Paper
